{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:13:09Z","timestamp":1779923589618,"version":"3.53.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.imbio.2005.10.002","type":"journal-article","created":{"date-parts":[[2005,10,21]],"date-time":"2005-10-21T07:13:38Z","timestamp":1129878818000},"page":"727-733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome"],"prefix":"10.1016","volume":"210","author":[{"given":"Ronald A.","family":"Asherson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2005.10.002_bib9","first-page":"482","article-title":"Primary antiphospholipid syndrome","volume":"16","author":"Alarcon-Segovia","year":"1989","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imbio.2005.10.002_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1053\/sarh.2001.27660","article-title":"Catastrophic antiphospholipid syndrome \u2013 remission following leg amputation in 2 cases (Review)","volume":"31","author":"Amital","year":"2001","journal-title":"Sem. Arthritis Rheum."},{"key":"10.1016\/j.imbio.2005.10.002_bib2","first-page":"1742","article-title":"A \u201cprimary\u201d antiphospholipid syndrome?","volume":"15","author":"Asherson","year":"1988","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imbio.2005.10.002_bib3","first-page":"508","article-title":"The catastrophic antiphospholipid syndrome","volume":"19","author":"Asherson","year":"1992","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imbio.2005.10.002_bib4","first-page":"12","article-title":"The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome \u2013 molecular mimicry?","volume":"27","author":"Asherson","year":"2000","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imbio.2005.10.002_bib5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005792-198911000-00004","article-title":"The \u201cprimary\u201d antiphospholipid syndrome: major clinical and serological features","volume":"68","author":"Asherson","year":"1989","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.imbio.2005.10.002_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005792-199805000-00005","article-title":"Catastrophic antiphospholipid syndrome. Clinical and laboratory features in 50 patients","volume":"77","author":"Asherson","year":"1998","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.imbio.2005.10.002_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00005792-200111000-00002","article-title":"Catastrophic antiphospholipid syndrome clues to the pathogenesis from a series of 80 patients","volume":"80","author":"Asherson","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.imbio.2005.10.002_bib8","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome (CAPS): international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.imbio.2005.10.002_bib10","first-page":"568","article-title":"Disseminated intravascular coagulation, antiphospholipid antibodies and ischemic necrosis of the extremities","volume":"56","author":"Bird","year":"1987","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imbio.2005.10.002_bib11","first-page":"2006","article-title":"Treatment of catastrophic antiphospholipid syndrome (CAPS) with defibrotide: a proposed vascular endothelial cell modulator","volume":"29","author":"Burcoglu-O\u2019Ral","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imbio.2005.10.002_bib12","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"Suppl 1","key":"10.1016\/j.imbio.2005.10.002_bib13","first-page":"FR10278","article-title":"A novel therapeutic approach for catastrophic antiphospholipid syndrome (CAPS) when conventional therapy with anticoagulants and steroids were unsuccessful","volume":"64","author":"Ehresmann","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imbio.2005.10.002_bib14","first-page":"843","article-title":"Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of the literature, and recommendations","volume":"29","author":"Erkan","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imbio.2005.10.002_bib15","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.62.6.530","article-title":"The long term outcome of catastrophic antiphospholipid syndrome survivors","volume":"62","author":"Erkan","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imbio.2005.10.002_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/jaut.2000.0403","article-title":"New developments in viral peptides and APL induction","volume":"15","author":"Gharavi","year":"2000","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imbio.2005.10.002_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archinte.1991.00400020129028","article-title":"Occlusive vasculopathy in systemic lupus erythematosus \u2013 association with anticardiolipin antibody","volume":"151","author":"Greisman","year":"1991","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.imbio.2005.10.002_bib18","first-page":"19","article-title":"Clinical and serological features of the \u201cantiphospholipid syndrome\u201d","volume":"26","author":"Harris","year":"1987","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.imbio.2005.10.002_bib19","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/art.1780301013","article-title":"An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies. Report of two cases","volume":"30","author":"Ingram","year":"1987","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imbio.2005.10.002_bib20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/rheumatology\/34.6.493","article-title":"Hughes syndrome: antiphospholipid antibodies move closer to thrombosis in 1994","volume":"34","author":"Khamashta","year":"1996","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.imbio.2005.10.002_bib21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0002-9343(98)00061-8","article-title":"Thrombotic storm. When thrombosis begets thrombosis","volume":"104","author":"Kitchens","year":"1998","journal-title":"Am. J. Med."},{"key":"10.1016\/j.imbio.2005.10.002_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0002-9343(91)90504-Q","article-title":"Infusion of a stable prostacyclin analogue, Iloprost, to patients with peripheral vascular disease: lack of antiplatelet effect but risk of thromboembolism","volume":"90","author":"Kovacs","year":"1991","journal-title":"Am. J. Med."},{"key":"10.1016\/j.imbio.2005.10.002_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/ard.48.5.362","article-title":"Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder","volume":"48","author":"Mackworth-Young","year":"1989","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imbio.2005.10.002_bib24","first-page":"195","article-title":"The catastrophic antiphospholipid syndrome \u2013 Asherson's syndrome","volume":"154","author":"Piette","year":"2003","journal-title":"Ann. Med. Interne (Paris)"},{"key":"10.1016\/j.imbio.2005.10.002_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1191\/0961203303lu396xx","article-title":"The systemic antiphospholipid syndrome","volume":"12","author":"Shoenfeld","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.imbio.2005.10.002_bib26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/1529-0131(199803)41:3<559::AID-ART23>3.0.CO;2-M","article-title":"Thrombotic events in patients with systemic sclerosis treated with Iloprost","volume":"41","author":"Tedeschi","year":"1998","journal-title":"Arthritis Rheum."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298505001403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298505001403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:20:43Z","timestamp":1759249243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298505001403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0171298505001403"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2005.10.002","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2005.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}